Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10years.

Kavsak PA, Worster A, Hill SA, MacRae AR, Jaffe AS.

Clin Chim Acta. 2017 Dec;475:51-55. doi: 10.1016/j.cca.2017.10.006. Epub 2017 Oct 7.

PMID:
29017768
2.

Letter by Kavsak and MacRae regarding article, "Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction".

Kavsak PA, MacRae AR.

Circulation. 2012 Feb 14;125(6):e358; author reply e359. doi: 10.1161/CIRCULATIONAHA.111.057885. No abstract available.

PMID:
22331927
3.

Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort.

Kavsak PA, Ko DT, Wang X, Macrae AR, Jaffe AS.

Clin Chem. 2010 Dec;56(12):1902-4. doi: 10.1373/clinchem.2010.153486. Epub 2010 Oct 12. No abstract available.

4.

Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study.

MacRae AR, Chodirker BN, Davies GA, Palomaki GE, Knight GJ, Minett J, Kavsak PA, Toi A, Chitayat D, Van Caeseele PG.

Prenat Diagn. 2010 May;30(5):459-66. doi: 10.1002/pd.2502.

PMID:
20440734
5.

2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay.

Kavsak PA, Ko DT, Wang X, Macrae AR, Jaffe AS.

Clin Chem. 2010 Mar;56(3):487-9. doi: 10.1373/clinchem.2009.136689. Epub 2010 Jan 14. No abstract available.

6.

Identification of myocardial injury in the emergency setting.

Kavsak PA, Worster A, You JJ, Oremus M, Elsharif A, Hill SA, Devereaux PJ, MacRae AR, Jaffe AS.

Clin Biochem. 2010 Apr;43(6):539-44. doi: 10.1016/j.clinbiochem.2009.12.014. Epub 2009 Dec 21. Review.

7.

The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department.

Kavsak PA, Newman AM, Ko DT, Macrae AR, Jaffe AS.

Clin Biochem. 2010 Mar;43(4-5):505-7. doi: 10.1016/j.clinbiochem.2009.11.004. Epub 2009 Nov 10.

8.

Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.

Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS.

Clin Chem. 2009 Oct;55(10):1809-15. doi: 10.1373/clinchem.2009.127241. Epub 2009 Aug 13.

9.

Another potential marker linking gender and cardiac mortality: PAPP-A--a new marker in risk stratification for women presenting with chest pain.

Kavsak PA, Henderson M, Ko DT, Wang X, MacRae AR, Jaffe AS.

Clin Chim Acta. 2009 Oct;408(1-2):139-40. doi: 10.1016/j.cca.2009.07.012. Epub 2009 Jul 29. No abstract available.

PMID:
19646427
10.

PAPP-A as a marker of increased long-term risk in patients with chest pain.

Kavsak PA, Wang X, Henderson M, Ko DT, MacRae AR, Jaffe AS.

Clin Biochem. 2009 Jul;42(10-11):1012-8. doi: 10.1016/j.clinbiochem.2009.03.015. Epub 2009 Mar 25.

11.

Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury.

Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS.

Clin Chem. 2009 Mar;55(3):573-7. doi: 10.1373/clinchem.2008.116020. Epub 2009 Jan 23.

12.

Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?

Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS.

Clin Chem. 2008 Apr;54(4):747-51. doi: 10.1373/clinchem.2007.094664.

13.

Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?

Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS.

Clin Biochem. 2008 Apr;41(6):436-9. doi: 10.1016/j.clinbiochem.2007.12.010. Epub 2007 Dec 27.

14.

The relationship between managed competition in home care nursing services and nurse outcomes.

Doran D, Pickard J, Harris J, Coyte PC, MacRae AR, Laschinger HS, Darlington G, Carryer J.

Can J Nurs Res. 2007 Sep;39(3):151-65.

PMID:
17970464
15.

"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, Macrae AR, Jaffe AS.

Clin Chim Acta. 2008 Jan;387(1-2):133-8. Epub 2007 Oct 3.

16.

Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS.

Clin Chem. 2007 Dec;53(12):2112-8. Epub 2007 Oct 11.

17.

The Relationship between Characteristics of Home Care Nursing Service Contracts under Managed Competition and Continuity of Care and Client Outcomes: Evidence from Ontario.

Doran D, Pickard J, Harris J, Coyte PC, Macrae AR, Laschinger H, Darlington G, Carryer J.

Healthc Policy. 2007 May;2(4):97-113.

18.

Authors' response to Apple editorial.

Kavsak PA, MacRae AR, Lustig V, Newman AM, Ko DT, Tu JV, Palomaki GE, Jaffe AS.

Clin Chim Acta. 2007 May 1;380(1-2):245-6. Epub 2007 Jan 23. No abstract available.

PMID:
17328878
19.

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.

Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Chim Acta. 2007 May 1;380(1-2):213-6. Epub 2007 Jan 23.

PMID:
17306781
20.

Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.

Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Biochem. 2007 Mar;40(5-6):326-9. Epub 2007 Jan 5.

PMID:
17292342
21.

Long-term health outcomes associated with detectable troponin I concentrations.

Kavsak PA, Newman AM, Lustig V, MacRae AR, Palomaki GE, Ko DT, Tu JV, Jaffe AS.

Clin Chem. 2007 Feb;53(2):220-7. Epub 2007 Jan 4.

22.

Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients.

Kavsak PA, MacRae AR, Palomaki GE, Newman AM, Ko DT, Lustig V, Tu JV, Jaffe AS.

Clin Chem. 2006 Nov;52(11):2028-35. Epub 2006 Sep 21.

23.

Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome.

Craig WY, Haddow JE, Palomaki GE, Kelley RI, Kratz LE, Shackleton CH, Marcos J, Stephen Tint G, MacRae AR, Nowaczyk MJ, Kloza EM, Irons MB, Roberson M.

Prenat Diagn. 2006 Sep;26(9):842-9.

PMID:
16832833
24.

The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.

Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS.

Am Heart J. 2006 Jul;152(1):118-25.

PMID:
16824840
25.

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.

Macrae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna MJ, Jaffe AS.

Clin Chem. 2006 May;52(5):812-8. Epub 2006 Mar 23.

26.

Second trimester serum markers.

Canick JA, MacRae AR.

Semin Perinatol. 2005 Aug;29(4):203-8. Review.

PMID:
16104669
27.

Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.

MacRae AR, Gardner HA, Allen LC, Tokmakejian S, Lepage N.

Clin Chem. 2003 Jan;49(1):69-76.

28.
29.

Mass transfer effects in solvent-free fat interesterification reactions: influences on catalyst design.

Ison AP, Macrae AR, Smith CG, Bosley J.

Biotechnol Bioeng. 1994 Jan 20;43(2):122-30.

PMID:
18615605
30.

Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome.

Wald NJ, Smith D, Kennard A, Palomaki GE, Salonen R, Holzgreve W, Pejtsik B, Coombes EJ, Mancini G, MacRae AR, et al.

Br J Obstet Gynaecol. 1993 May;100(5):430-5.

PMID:
8518242
31.

Lipases from different sources vary widely in dependence of catalytic activity on water activity.

Valivety RH, Halling PJ, Peilow AD, Macrae AR.

Biochim Biophys Acta. 1992 Jul 31;1122(2):143-6.

PMID:
1643087
32.

Use of specific polyclonal antibodies to detect heterogeneous lipases from Geotrichum candidum.

Charton E, Davies C, Macrae AR.

Biochim Biophys Acta. 1992 Jul 29;1127(2):191-8.

PMID:
1643106
33.

Rhizomucor miehei lipase remains highly active at water activity below 0.0001.

Valivety RH, Halling PJ, Macrae AR.

FEBS Lett. 1992 Apr 27;301(3):258-60.

34.

Reaction rate with suspended lipase catalyst shows similar dependence on water activity in different organic solvents.

Valivety RH, Halling PJ, Macrae AR.

Biochim Biophys Acta. 1992 Feb 1;1118(3):218-22.

PMID:
1737045
35.

Substrate specificities of lipases A and B from Geotrichum candidum CMICC 335426.

Charton E, Macrae AR.

Biochim Biophys Acta. 1992 Jan 3;1123(1):59-64.

PMID:
1730047
36.

Geotrichum candidum produces several lipases with markedly different substrate specificities.

Sidebottom CM, Charton E, Dunn PP, Mycock G, Davies C, Sutton JL, Macrae AR, Slabas AR.

Eur J Biochem. 1991 Dec 5;202(2):485-91.

38.

Tailored triacylglycerols and esters.

Macrae AR.

Biochem Soc Trans. 1989 Dec;17(6):1146-8. No abstract available.

PMID:
2628122
39.
40.
41.

A comparison of the effects of an oral fructose load in hypertriglyceridaemic and normolipidaemic men.

MacRae AR, Macdonald I.

Proc Nutr Soc. 1975 Sep;34(2):54A-55A. No abstract available.

PMID:
1187622
42.

Proceedings: The influence of fat in the meal on oral glucose tolerance.

MacRae AR, Macdonald I.

Proc Nutr Soc. 1974 Sep;33(2):26A-27A. No abstract available.

PMID:
4480383
43.

Studies on carbohydrate digestibility and weight gain response in rats fed dietary sucrose, glucose or fructose.

MacRae AR, Slinger SJ, Neudoerffer TS.

Nutr Metab. 1974;17(1):37-46. No abstract available.

PMID:
4415936
44.

Carcass composition and weight gain response of rats fed various carbohydrates at two dietary levels of carbohydrate and protein.

MacRae AR, Nickel I, Slinger SJ, Neudoerffer TS.

Nutr Metab. 1974;17(1):47-54. No abstract available.

PMID:
4412317
45.

The effect of various carbohydrates on weight gain and carcass composition in the rat.

MacRae AR, Slinger SJ, Nickel I, Neudoerffer TS.

Proc Nutr Soc. 1973 May;32(1):29A-30A. No abstract available.

PMID:
4760783
46.

Support for the existence of an active transport mechanism of fructose in the rat.

Macrae AR, Neudoerffer TS.

Biochim Biophys Acta. 1972 Oct 23;288(1):137-44. No abstract available.

PMID:
4640382
47.
48.

The oxidation of malate by mitochondria isolated from cauliflower buds.

Macrae AR, Moorhouse R.

Eur J Biochem. 1970 Sep;16(1):96-102. No abstract available.

Supplemental Content

Loading ...
Support Center